FIGURE

Figure 2

ID

ZDB-FIG-210822-2

Publication

Heliste et al., 2021 - Combined genetic and chemical screens indicate protective potential for EGFR inhibition to cardiomyocytes under hypoxia

Other Figures

All Figure Page

Back to All Figure Page

Figure 2

Drug library screening to identify compounds affecting cardiomyocyte viability. Schematic overview of the drug library screen. HL-1 cells were plated with a drug library consisting of 689 FDA-approved compounds. Cells were exposed to hypoxia-reoxygenation for a viability dropout screen. As the readout, cellular viability was measured with CTG assays. (b) Effect of hypoxia-reoxygenation on the viability of DMSO-treated control cells (22% reduction in relative viability (P < 0.001)). (c) Scatter plot of DMSO-normalized relative viability values in normoxia vs. hypoxia-reoxygenation for each drug concentration. Correlation curve depicts the linear model of the correlation of the values between treatments. Horizontal line depicts the average viability of DMSO-treated cells in hypoxia-reoxygenation. Significant viability-improving effects are depicted with red dots for the maximally effective drug concentrations. The dot representing gefitinib is indicated in blue.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Sci. Rep.